IL6 and cervical adenocarcinoma: Overall, miR‐9 has the potential to suppress tumors in cervical adenocarcinoma and suggests repression of tumorigenesis through inhibition of the IL‐6/Jak/STAT3 pathway (Zhang et al., 2016).